US pharma tariffs could have significant impact on Irish corporate tax receipts 

Punitive tariff measures may lead to lower profits, hence, lower corporate tax receipts to the Irish Exchequer, says Ifac chairman Seamus Coffey

President Donald Trump speaks during a cabinet meeting at the White House in Washington, Monday, March 24, 2025. (Pool via AP)

US President Donald Trump's plan to impose tariffs on the pharmaceutical industry has raised several concerns for the Irish economy, with his punitive measures putting Ireland's lucrative corporate tax receipts at risk.

Speaking this week, the US President said he would try to "bring our pharmacy industry back," calling out Ireland and China specifically as countries benefiting from US companies.